...
首页> 外文期刊>Cell death & disease. >Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression
【24h】

Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression

机译:长非编码RNA SNHG20通过表观遗传上的P21表达沉默促进非小细胞肺癌细胞的增殖和迁移

获取原文
           

摘要

Mounting evidence demonstrates that long non-coding RNAs (lncRNAs) are novel transcripts governing multiple biological processes, and their dysregulation is involved in the development and progression of multiple types of cancers. Small Nucleolar RNA Host Gene 20 (SNHG20) is a 2183?bp lncRNA, and its overexpression predicts poor prognosis in colorectal cancer and hepatocellular carcinoma. However, the clinical relevance of SNHG20 and its molecular mechanisms affecting cancer cell phenotype have not been documented. Here, we found that SNHG20 was upregulated in non-small cell lung cancer (NSCLC) tissues compared with normal samples. Higher SNHG20 expression was significantly associated with advanced tumor, lymph node and metastases (TNM) stage and tumor size, as well as poorer overall survival. Moreover, knockdown of SNHG20 repressed NSCLC cell proliferation, migration and induced cell apoptosis. Mechanistic investigations revealed that SNHG20 could interact with EZH2 (enhancer of zeste homolog 2), thereby repressing P21 expression. Furthermore, rescue experiments indicated that SNHG20 functioned as an oncogene partly via repressing p21 in NSCLC cells. Taken together, our findings demonstrate that SNHG20 is a new candidate for use in NSCLC diagnosis, prognosis and therapy.
机译:越来越多的证据表明,长的非编码RNA(lncRNA)是支配多种生物过程的新型转录本,其失调与多种癌症的发生和发展有关。小核仁RNA宿主基因20(SNHG20)是一个2183?bp的lncRNA,其过表达预示着结直肠癌和肝细胞癌的不良预后。但是,尚未报道SNHG20的临床相关性及其影响癌细胞表型的分子机制。在这里,我们发现与正常样品相比,SNHG20在非小细胞肺癌(NSCLC)组织中上调。较高的SNHG20表达与晚期肿瘤,淋巴结转移(TNM)阶段和肿瘤大小以及较差的总体生存率显着相关。此外,SNHG20的组合式抑制NSCLC细胞增殖,迁移和诱导细胞凋亡。机理研究表明,SNHG20可以与EZH2(zeste同源2的增强子)相互作用,从而抑制P21的表达。此外,救援实验表明SNHG20部分通过抑制NSCLC细胞中的p21发挥癌基因的作用。综上所述,我们的发现证明SNHG20是用于NSCLC诊断,预后和治疗的新候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号